Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
41.06
-0.05 (-0.12%)
Apr 29, 2026, 9:44 AM CST
7.54%
Market Cap 19.34B
Revenue (ttm) 1.56B
Net Income (ttm) -564.85M
Shares Out 470.34M
EPS (ttm) -1.32
PE Ratio n/a
Forward PE 43.73
Dividend n/a
Ex-Dividend Date n/a
Volume 296,767
Average Volume 3,870,871
Open 41.00
Previous Close 41.11
Day's Range 40.62 - 41.11
52-Week Range 35.20 - 89.04
Beta 0.73
RSI 47.49
Earnings Date Apr 23, 2026

About Sinocelltech Group

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar for the treatment of various autoimmune diseases; Anbezu, a bevacizumab biosimilar for the ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,242
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.